Unlock potential by leading CMC regulatory activities for IND/CTA development. Drive compliance and quality in submissions, assess CMC changes, and collaborate cross-functionally to support clinical trials and global regulatory strategies.

Lead the transformation of biometrics activities for oncology drug development, overseeing teams in biostatistics, programming, and data management while ensuring regulatory compliance and developing a high-performing organization.

Reimagine cancer treatment through innovative biometrics leadership, driving biostatistics, programming, and data management for clinical trials. Mentor teams, influence regulatory strategies, and collaborate with cross-functional executives.